SCHEMBL26147486

SCHEMBL26147486

CC(C)C(=O)CCN1C2CCC1CN(C(C)C)C2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7859490 0.77 HTR4 (0.33)
SCHEMBL26147490 0.76 SMN1; SMN2 (0.31)
SCHEMBL26147487 0.74
SCHEMBL25654363 0.74 ALDH1A1 (0.34)
SCHEMBL25957483 0.74 HTR4 (0.32)
SCHEMBL26147488 0.73 ALDH1A1 (0.34)
SCHEMBL20009105 0.71
SCHEMBL26147493 0.71
SCHEMBL24996457 0.70
SCHEMBL18806173 0.70

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230150974-A1 COMPOUNDS AND USES THEREOF FOGHORN THERAPEUTICS INC. 2023-05-18 US disclosed
US-20230150974-A1 COMPOUNDS AND USES THEREOF FOGHORN THERAPEUTICS INC. 2023-05-18 US disclosed